Berberine is a modest metabolic adjunct, not a weight-loss drug. Randomized trials show it can lower blood sugar and improve insulin resistance — mostly in people who already have type 2 diabetes, metabolic syndrome, fatty liver, or PCOS.
The "Ozempic dupe" framing doesn't hold up. The weight-loss studies are few, small, and done in people who already had metabolic disease. There's no reliable evidence berberine produces meaningful weight loss on its own.
It is not a GLP-1 medication. Berberine activates an energy-sensing enzyme (AMPK); GLP-1 drugs mimic an appetite-regulating hormone and have large, rigorous trials behind them. Different category entirely.
It has real drug interactions. Berberine can raise blood levels of other medications and should never be layered onto an existing medication list without clinician review.